Purpose: Current and future treatment modalities for Clostridium difficile-associated disease (CDAD) are reviewed. Conclusion: CDAD is a major concern for health care systems and clinicians.

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Clostridium difficile exists in soil ... when a person touches surfaces or objects containing the bacteria. Standard treatment for C. difficile infection is oral antibiotics to stop the growth ...

Even if outbreaks of acne cannot be eliminated, conventional treatment can provide relief. The best treatments inhibit sebum production, limit bacterial growth, encourage shedding of skin cells to ...

Simon Parkinson had no coordination or movement in his right arm and leg when he was restrained and transported to hospital ...

Here’s our process. If you’re managing a sexually transmitted infection (STI), you have options for treatment. While you can visit a healthcare professional in person for an evaluation and ...

Identifying infection, treating it appropriately, and reviewing efficacy of the treatment is a skill that all clinical practitioners should ... This can have serious implications for the patient, as ...

Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...

But I think we and they both believed that because nobody had done a study in this disease, [and] because this would be a treatment that ... the C. difficile candidate. Gibson: Yeah, that ...